Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization

Current evidence indicates that the next-generation probiotic Akkermansia muciniphila (A. muciniphila) has therapeutic potential for nonalcoholic fatty liver disease (NAFLD), especially its inflammatory stage known as nonalcoholic steatohepatitis (NASH). However, the mechanisms of A. muciniphila in...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yuqiu, Ling, Qi, Wu, Li, Wang, Xiaosen, Wang, Zhifei, Chen, Jun, Zheng, Zhipeng, Zhou, Ziyuan, Jia, Longfei, Li, Lanjuan, Wang, Baohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288935/
https://www.ncbi.nlm.nih.gov/pubmed/37345844
http://dx.doi.org/10.1080/19490976.2023.2221485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288935/
https://www.ncbi.nlm.nih.gov/pubmed/37345844
http://dx.doi.org/10.1080/19490976.2023.2221485

Ejemplares similares